Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127132033 | 12713203 | 3 | F | 20160908 | 20160902 | 20160922 | EXP | ES-TEVA-688916ISR | TEVA | PASCUAL O. TWO CASES OF BREAST CARCINOMA DURING PREGNANCY AND REVIEW OF THE LITERATURE. J-ONCOL-PHARM-PRACT. 2016 JAN 01;22:652-656. | 33.00 | YR | F | Y | 0.00000 | 20160922 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127132033 | 12713203 | 1 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | AT DAYS 1-3; 2 CYCLES. | D | 63097 | 25 | MG/M**2 | Q3W | ||||||
| 127132033 | 12713203 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | Y | 75297 | 80 | MG/M**2 | /wk | |||||||
| 127132033 | 12713203 | 3 | C | ondansetron | ONDANSETRON | 1 | Intravenous (not otherwise specified) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127132033 | 12713203 | 1 | Intraductal proliferative breast lesion |
| 127132033 | 12713203 | 2 | Intraductal proliferative breast lesion |
| 127132033 | 12713203 | 3 | Antiemetic supportive care |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127132033 | 12713203 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127132033 | 12713203 | Abdominal discomfort | |
| 127132033 | 12713203 | Anaemia | |
| 127132033 | 12713203 | Asthenia | |
| 127132033 | 12713203 | Exposure during pregnancy | |
| 127132033 | 12713203 | Fatigue | |
| 127132033 | 12713203 | Mucosal inflammation | |
| 127132033 | 12713203 | Neutropenia | |
| 127132033 | 12713203 | Normal newborn | |
| 127132033 | 12713203 | Pyrexia | |
| 127132033 | 12713203 | Respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |